Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-15

FDA Approved: ALPRAZOLAM — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal Pharmaceuticals LLC's supplemental application for Alprazolam (generic) under ANDA078387, signaling a supplemental approval of a generic alp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)